Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 9/20 | 0.73 |
| ▸ | MAOB | P27338 | 9/20 | 0.73 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.55 |
| ▸ | TGM2 | P21980 | 5/20 | 0.53 |
| ▸ | CES1 | P23141 | 4/20 | 0.50 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28316144 | 0.85 | ACVR1 (0.57) | MAOAMAOBPDE3BPDE3AGSTP1 | |
| SCHEMBL2789935 | 0.84 | MAOA (1.00) | MAOAMAOBPDE3BPDE3ASLC6A11 | |
| SCHEMBL3737924 | 0.78 | MAOA (0.57) | MAOAMAOBTGM2CES1ALDH1A1 | |
| SCHEMBL25367285 | 0.77 | MAOA (0.74) | MAOAMAOBPDE3BPDE3ASLC6A11 | |
| SCHEMBL30588923 | 0.77 | MAOA (0.74) | MAOAMAOBPDE3BPDE3ASLC6A11 | |
| Isatin SCHEMBL28193470 | 0.76 | MAOA (0.87) | MAOAMAOBTGM2CES1ALDH1A1 | |
| SCHEMBL2788548 | 0.76 | MAOB (0.72) | MAOAMAOBPDE3BPDE3ASLC6A11 | |
| SCHEMBL29906173 | 0.76 | MAOB (0.72) | MAOAMAOBPDE3BPDE3ASLC6A11 | |
| SCHEMBL4370977 | 0.76 | CES1 (0.73) | MAOAMAOBPDE3BPDE3ASLC6A11 | |
| SCHEMBL3521129 | 0.75 | MAOA (0.71) | MAOAMAOBPDE3BPDE3ASLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152455-A1 | ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2010-06-17 | — | — | US | disclosed |
| CN-101641423-A | Organometallic compound for electroluminescence and organic electroluminescent device using the same | GRACEL DISPLAY INC KR | 2010-02-03 | — | — | CN | disclosed |
| EP-2092040-A1 | ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMIESCENT DEVICE USING THE SAME | Gracel Display Inc. (KR) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008082249-A1 | ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMIESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2008-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152455-A1 | ORGANOMETALIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | EPCAM, ORC3, L1CAM | MAOA 1001/4885MAOB 1137/4885PDE3B 4735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.